Back to Back Issues Page
Maculaser for Early Macular Degeneration Intervention
January 07, 2020

Maculaser for Early Macular Degeneration Intervention

So much macular degeneration research focuses on wet macular degeneration and how to restore vision losses or how to prevent further progression of wet AMD. The majority of clinical trials for dry macular degeneration are for patients who have the advanced form called geographic atrophy.

However, a new form of treatment called Maculaser is seeking to "treat the root causes of AMD: reduce oxidative stress, prevent the aggregation of proteins, improve transport of nutrients, and enhance RPEs cytoprotective mechanisms, i.e. they stimulate the natural, biological healing response of RPE" reports the Maculaser website.

Near-infrared Laser

Aalto University in Espoo, Finland has been researching the use of near-infrared laser and precise temperature control for the back of the eye since 2013. Maculaser works by by heating up the layer of the retina called the retinal pigment epithelium (RPE).

The key is to provide just the right optimal heat temperature that offers regenerative benefits without harming delicate retinal tissue. The Maculaser method is able to determine retinal temperature through electroretinogram responses.

"Heat treatment of the fundus is not a new invention, but until now, it has not been possible to monitor the temperature of the retinal pigment epithelium while the treatment is administered. This is essential in order to avoid damage to the tissues being treated', explains researcher Teemu Turunen.

Find out more about this research that seeks to "halt the development of the condition in its early stages and to prevent it from progressing to the dry or wet form."

Early Intervention Using Maculaser

Leslie Degner, RN, BSN

Better Health for Better Vision

Back to Back Issues Page